This topic contains a solution. Click here to go to the answer

Author Question: Physicians may be owed additional ____________________ amounts for new members who do not choose a ... (Read 17 times)

SGallaher96

  • Hero Member
  • *****
  • Posts: 509
Physicians may be owed additional ___________________ _ amounts for new members who do not choose a PCP and to whom a physician is assigned after a given period of time.
 
  a. exclusionary
  b. withheld
  c. capitation
  d. copayment

Question 2

When there is a discrepancy with the eligibility roster and the patients seen, and the biller determines the error on the part of the HMO, a ___________________ ____ is used to bill for the missing capitation amount.
 
  a. Supplemental Capitation Request form
  b. Error in Eligibility List Notification form
  c. copy of the insured's membership card
  d. health care claim form



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Animal_Goddess

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

Answer: c

Answer to Question 2

Answer: a




SGallaher96

  • Member
  • Posts: 509
Reply 2 on: Jun 27, 2018
Wow, this really help


tranoy

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Excellent

 

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

For a complete list of videos, visit our video library